DS
UTMD icon

David Shaw’s Utah Medical Products UTMD Stock Holding History

David Shaw’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$603K Hold
8,735
– – ﹤0.01% 4084
2026
Q1 		$541K Sell
8,735
-100
-1% -$6.3K ﹤0.01% 3816
2025
Q4 		$494K Sell
8,835
-346
-4% -$20.1K ﹤0.01% 3935
2025
Q3 		$578K Sell
9,181
-106
-1% -$6.27K ﹤0.01% 3792
2025
Q2 		$529K Sell
9,287
-421
-4% -$22.9K ﹤0.01% 3615
2025
Q1 		$544K Hold
9,708
– – ﹤0.01% 3459
2024
Q4 		$597K Sell
9,708
-405
-4% -$26.2K ﹤0.01% 3508
2024
Q3 		$677K Sell
10,113
-674
-6% -$45.8K ﹤0.01% 3522
2024
Q2 		$721K Sell
10,787
-5,464
-34% -$372K ﹤0.01% 3396
2024
Q1 		$1.16M Buy
16,251
+11,747
+261% +$881K ﹤0.01% 3000
2023
Q4 		$379K Sell
4,504
-212
-4% -$17.6K ﹤0.01% 3645
2023
Q3 		$406K Buy
4,716
+1,886
+67% +$174K ﹤0.01% 3505
2023
Q2 		$264K Buy
2,830
+442
+19% +$41.6K ﹤0.01% 3644
2023
Q1 		$226K Buy
2,388
+300
+14% +$27.6K ﹤0.01% 3853
2022
Q4 		$210K Buy
+2,088
New +$191K ﹤0.01% 4231
2022
Q2 		– Sell
-2,831
Closed -$254K – 5798
2022
Q1 		$254K Buy
+2,831
New +$260K ﹤0.01% 4739

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $158M AUM 42.05% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

David Shaw's UTMD Position: Q2 2026 in Review

David Shaw held its Utah Medical Products (UTMD) position steady in Q2 2026 at 8,735 shares worth $603K. The position accounts for ﹤0.01% of the portfolio, ranked #4084.

David Shaw first reported a position in UTMD in Q1 2022 and has held it in 16 quarters since. The position peaked at $1.16M in Q1 2024. 113 funds tracked by Wall St. Rank hold UTMD as of Q2 2026.

  • David Shaw held 8,735 shares of Utah Medical Products worth $603K as of Q2 2026.
  • David Shaw left its Utah Medical Products share count unchanged in Q2 2026.
  • Utah Medical Products made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #4084 holding.
  • David Shaw first reported a position in Utah Medical Products in Q1 2022 and has held it in 16 quarters since.
  • David Shaw's Utah Medical Products position peaked at $1.16M in Q1 2024.
  • 113 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.